1. Anti‐idiotype monoclonal antibodies against emicizumab enable accurate procoagulant and anticoagulant assays, irrespective of the test base, in the presence of emicizumab. Issue 1 (22nd September 2022) Authors: Ogiwara, Kenichi; Furukawa, Shoko; Shinohara, Sho; Tabuchi, Yuka; Arai, Nobuo; Noguchi‐Sasaki, Mariko; Soeda, Tetsuhiro; Shima, Midori; Nogami, Keiji Journal: Haemophilia Issue: Volume 29:Issue 1(2023) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Detailed analysis of anti‐emicizumab antibody decreasing drug efficacy, using plasma samples from a patient with hemophilia A. (28th September 2021) Authors: Kaneda, Makoto; Kawasaki, Ryohei; Matsumoto, Naoki; Abe, Hiroto; Tashiro, Yoshihito; Inokuchi, Yuta; Yasuno, Hideyuki; Sasaki‐Noguchi, Mariko; Soeda, Tetsuhiro; Yoshimura, Yasushi; Oka, Toshiaki Journal: Journal of thrombosis and haemostasis Issue: Volume 19:Number 12(2021) Page Start: 2938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Emicizumab improves the stability and structure of fibrin clot derived from factor VIII‐deficient plasma, similar to the addition of factor VIII. Issue 3 (11th March 2020) Authors: Shimonishi, Naruto; Nogami, Keiji; Ogiwara, Kenichi; Matsumoto, Tomoko; Nakazawa, Fumie; Soeda, Tetsuhiro; Hirata, Michinori; Arai, Nobuo; Shima, Midori Journal: Haemophilia Issue: Volume 26:Issue 3(2020) Page Start: e97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The factor VIII heavy chain improves emicizumab-tenase assembly to enhance the factor VIII-mimicking cofactor activity. Issue 166 (June 2018) Authors: Minami, Hiroaki; Nogami, Keiji; Soeda, Tetsuhiro; Kitazawa, Takehisa; Hattori, Kunihiro; Shima, Midori Journal: Thrombosis research Issue: Issue 166(2018) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗